Sarah Cannon’s research capabilities:
Sarah Cannon Research Institute is a global strategic research organization focused on advancing therapies for patients. It is one of the largest clinical research programs, conducting community-based clinical trials in oncology, cardiology and orthopedics through affiliations with a network of partnering physicians in the United States and United Kingdom.
Additionally, Sarah Cannon Research Institute offers management, regulatory and other research support services to drug development sponsors and strategic investigator sites. Sarah Cannon Research Institute sponsors oncology clinical trials through its affiliation with clinical oncology practices.
This work makes it possible for thousands of cancer patients to participate in research studies in the communities where they live. Sarah Cannon Research Institute provides research support services to oncologists, hematologists and drug development sponsors from around the world.